BACKGROUND AND PURPOSE {#sec1-1}
======================

Both age and diabetes mellitus (DM) are independent prognostic predictors of hospital mortality in Acute Coronary Syndrome (ACS).\[[@ref1]\] An analysis on the in-hospital events and 6 months outcomes in elderly patients with ACS who were included in the GRACE registry showed that the more elderly, the higher risk are the patients, the less frequently coronary angiography, and revascularization are used in spite of an increasing GRACE risk score.\[[@ref2]\] There is paucity of data in Kingdom of Saudi Arabia (KSA) despite the high percentage of elderly diabetic patients and the high prevalence of DM.

Multicenter International Diabetes -- Acute Coronary Syndromes (MIDAS) study aimed to monitor the adherence to evidence-based therapy of diabetic patients with ACS and to describe the in-hospital outcomes of diabetic patients in the setting of ACS.\[[@ref3][@ref4]\] We present the characteristic risk profile and points of concern in the management of elderly patients in the KSA in comparison to the international data.

DESIGN {#sec1-2}
======

MIDAS is an observational registry and diagnostic, monitoring, or therapeutic procedures were not applied to the patients. DM patients presenting with Non ST Elevation -- Acute Coronary Syndrome were enrolled into the study at the time of admission to the emergency room or the coronary care unit in five hospitals in KSA. A total of 3624 patients were enrolled; 142 were from Saudi Arabia. Primary clinical outcome measure was in-hospital death or myocardial infarction (MI). MIDAS did not interfere with the medical care of the patients, which was done according to local practice.

RESULTS {#sec1-3}
=======

Baseline characteristics for MIDAS participants were typical of diabetics with ACS. The mean age was 67 ± 15 years and there was female predominance (64%). DM type 2 constitutes 94% of the patients\[[Table 1](#T1){ref-type="table"}\].

###### 

Baseline characteristics for multicenter international diabetes -- acute coronary syndromes patients
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The utilization of glycoprotein IIb/IIIa inhibitors in international MIDAS was 37.4%, predominantly Tirofiban, in comparison to 18.3% in KSA (*P* = 0.046). There was marked underutilization of glycoprotein IIb/IIIa inhibitors in KSA in those ≥65 years (12.7%) in comparison to 22.5% in those \<65 years (Odds ratio 0.56). Meanwhile, the utilization of GP IIb/IIIa in international MIDAS elderly population decreased from 40.8% in those aged \<65 years to 35.7% in those aged ≥65 years with Odds ratio 0.87 \[[Figure 1](#F1){ref-type="fig"}\].
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On the contrary, the utilization of clopedogril/ticlopidine in KSA was 96.8% exceeding the international figure of 74.7% ( P \< 0.0001). Surprisingly, the utilization of clopedogril/ticlopidine in KSA in those aged ≥65 years (98.2%) was higher than those aged \<65 years (95.8%) \[[Figure 2](#F2){ref-type="fig"}\].

The percentage of early coronary angiography approach in KSA was less than that of the international data with further drop of the percentage in Saudi elderly population (25.5% in those aged over 65 years) in comparison to 49.3% in those aged \<65 years with Odds ratio 0.52. Meanwhile, there was mild drop in the international figure (42.5% in those aged ≥65 years in comparison to 53.4% in those aged \<65 years with Odds ratio 0.80) \[[Figure 3](#F3){ref-type="fig"}\].

In contrast, the percentage of Per Cutaneuos coronary Intervention procedures in Saudi elderly patients (23.6% in those aged ≥65 years) was very close to those aged \<65 years (25.4%), but much less than the international elderly (≥65 years), who had percutaneous coronary intervention (PCI) in 42.5% \[[Figure 4](#F4){ref-type="fig"}\].
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The percentage of patients who had Coronary Artery Bypass Graft in elderly KSA (≥65years) was 7.3% in comparison to 12.7% in those aged \<65 years. The international figure in those aged ≥ 65 years (8.9%) did not show remarkable difference in comparison with those aged \<65 years (9.4%)\[[Figure 5](#F5){ref-type="fig"}\].

![Percentage of CABG based on age group](HV-14-1-g006){#F5}

DISCUSSION {#sec1-4}
==========

One study in Saudi subjects showed that, in those aged over 60 years, the prevalence of Non Insulin Dependant Diabetic Mellitus was 28.82% in males and 24.92% in females. Furthermore, DM was the most prevalent risk factor for coronary artery disease, present in 56% of patients.\[[@ref5]\] However, data regarding the adherence to evidence-based therapy in this group of patients are lacking.

Elderly are at the risk of being under-treated both medically and by interventions as supported by recent registries and statements;\[[@ref1][@ref2]\] however, the available data from KSA are few.

The mean age of MIDAS patients (65 years) was similar to that of GRACE registry (66 years) and NCDR ACTION registry (64 years).\[[@ref6][@ref7]\] Data from MIDAS showed, in general, satisfactory use of evidence-based therapies. However, there were significant differences in utilization of different lines of treatment based on age.

Elderly patients were under-treated in the invasive arm in term of coronary angiography, PCI, and coronary artery bypass graft (CABG). This was more marked in elderly Saudi patients. Despite the current strong recommendations for their use in diabetics presenting with ACS, there was marked underutilization of GP IIb/IIIa inhibitors in elderly Saudi MIDAS patients as well as those aged under 65 years. This underutilization was obviously due to fear of bleeding, taking into consideration that recent reports and guidelines showed more concern about the increased risk of bleeding upon using double or triple antiplatelet therapy in combination with heparin.

In contrast, the use of clopedogril/ticlopidine in KSA was in total compliance and it exceeded the international data and the 86% achieved by the top 10% performing hospitals in ACTION registry. This observation might have been related to the use of clopedogril in patients who did not receive GP IIb/IIIa inhibitors due to the fear of bleeding.

Although coronary angiography approach in KSA was matching in those aged less than 65 years, there was significant difference in the Saudi elderly population, probably due to fear of complications. This differential treatment needs to be addressed.

In contrast, the percentage of PCI procedures in Saudi elderly patients was very close to those aged less than 65 years. This might be explained by the bad coronary anatomy of Saudi diabetic patients, who are noted to have high glycosylated hemoglobin (Hb~a1c~).

Underutilization of CABG was noted in Saudi elderly. This percentage was close to that of patients who had CABG in the setting of acute coronary event in The Saudi Project for Assessment of Coronary Events (SPACE) registry (9%);\[[@ref8]\] whereas in the SPACE registry, the percentage of early coronary angiography (60%) and PCI (39%) exceeds that of the Saudi MIDAS population. This also might be related to the difference in the number of the centers that have cardiac catheterization laboratories in each study.

One of the restriction on these data is the selective involvement of certain cardiac centers, however, this will invite for further studies in this group.

CONCLUSIONS {#sec1-5}
===========

Elderly KSA patients tend to have less use of utilization of GP IIb/IIIa and early coronary angiography and CABG but not clopedogril/ticlopidine. This concern needs further attention by health authority, since elderly patients represent a very high-risk group that may benefit the most from intensive medical therapy and early coronary angiography.
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